EP Patent

EP2754463A2 — Expandable devices

Assigned to Intersect ENT Inc · Expires 2014-07-16 · 12y expired

What this patent protects

The devices (100) generally comprise a hub (102) and a plurality of legs (104) extending therefrom. In some variations, the hub may comprise one or more domed portions, tapered portions, or the like. The legs may comprise one or more straight segments, one or more curved segments…

USPTO Abstract

The devices (100) generally comprise a hub (102) and a plurality of legs (104) extending therefrom. In some variations, the hub may comprise one or more domed portions, tapered portions, or the like. The legs may comprise one or more straight segments, one or more curved segments, or a combination thereof. The devices may comprise one or more polymers, and/or one or more portions of the device may be configured to biodegrade. In other variations, the device may be configured to release one or more drugs therefrom. Additionally, in some variations the devices may be configured to be self-expandable from a low-profile configuration to an expanded configuration.

Drugs covered by this patent

Patent Metadata

Patent number
EP2754463A2
Jurisdiction
EP
Classification
—
Expires
2014-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Intersect ENT Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.